TOt-HER3

Home Tag

Cristina Saura-8

SOLTI-TOT-HER3 window of opportunity trial: final results show that lower dose patritumab deruxtecan is less toxic and does not compromise efficacy in the treatment of breast cancer

Presented at the 2023 ESMO Breast Cancer Annual Congress, 11-13 May in Berlin, final results of the SOLTI-TOT-HER3 window of…